Cx Institutional Viatris Inc Transaction History

Cx Institutional

$2.24 Billion
Q3 2024

A detailed history of Cx Institutional transactions in Viatris Inc stock. As of the latest transaction made, Cx Institutional holds 12,437 shares of VTRS stock, worth $161,681. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,437

Previous 12,005 3.6%

Holding current value

$161,681

Previous $127,000 13.39%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$10.32 - $12.13 $4,458 - $5,240	432 Added 3.6%	12,437 $144,000
Q2 2024 Jul 11, 2024	BUY	$10.05 - $12.02 $653 - $781	65 Added 0.54%	12,005 $127,000
Q1 2024 Apr 15, 2024	SELL	$11.27 - $13.53 $1,690 - $2,029	-150 Reduced 1.24%	11,940 $142,000
Q4 2023 Jan 12, 2024	BUY	$8.77 - $10.85 $106,029 - $131,176	12,090 New	12,090 $130,000
Q2 2023 Jul 26, 2023	BUY	$9.02 - $10.29 $149,695 - $170,772	16,596 Added 5.19%	336,112 $3.35 Million
Q1 2023 May 04, 2023	BUY	$9.2 - $12.26 $2.94 Million - $3.92 Million	319,516 New	319,516 $3.07 Million
Q2 2022 Aug 02, 2022	BUY	$9.95 - $12.27 $13,920 - $17,165	1,399 New	1,399 $14,000
Q4 2021 Jan 18, 2022	SELL	$12.09 - $14.68 $7,483 - $9,086	-619 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$13.25 - $15.13 $2,663 - $3,041	-201 Reduced 24.51%	619 $8,000
Q2 2021 Aug 04, 2021	BUY	$12.97 - $16.15 $5,045 - $6,282	389 Added 90.26%	820 $12,000
Q1 2021 Apr 15, 2021	SELL	$13.59 - $18.54 $339 - $463	-25 Reduced 5.48%	431 $6,000
Q4 2020 Jan 12, 2021	BUY	$14.3 - $18.74 $6,520 - $8,545	456 New	456 $8,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Viatris Inc Transaction History